Hugo delivers real-world data to help researchers transform data into evidence.


 
Hugo Dash image.png

Overcoming Existing Barriers

  • Make real world data sources accessible to researchers

  • Establish a framework and a methodology to capture RWD

  • Develop methodologies to integrate RWD and verify patient identity across multiple sources

  • Earn patient/participant trust and engagement


Accelerating
Research

  • Simplify infrastructures

  • Streamline collection of data from multiple sources and across health plans and care providers in near real-time (EHR, pharmacy, reference labs)

  • Supplement traditional data sources with patient reported and patient generated data

  • Provide long-term, longitudinal data

  • Decrease loss to follow-up


Ideal Use Cases For Hugo

Group 2.png

Outcomes-based research

Group 3.png

Post Market Surveillance/Registries

Group 4.png

Label Expansion


Validated technology and novel partnership
with people enable access to comprehensive, longitudinal, real world data.

Hugo Data flow.001.jpeg

 
 

AUTO-UPDATED CLINICAL DATA

Study participants link patient portals at health systems and pharmacies with their Hugo account.  Opting to share data with a study initiates an automated, ongoing transfer of data directly to the study database.

 
05_ timeline2.png
 

 
 
 
 

SECURE PATIENT-REPORTED DATA

Hugo provides a method of delivering customized surveys directly to users’ mobile devices and opens a new channel of communication between researcher and study participant.

 

 
 

PATIENT-GENERATED DATA

Link fitness trackers and other devices or sensors to collect data on symptoms, function, sleep, appetite, activity, and more to supplement study participant’s longitudinal record

 
 
 

“Hugo holds the promise to empower people with their data and will create innumerable opportunities for them to participate in programs and projects that are customized to their interests and needs — and provides opportunities to be part of communities that contribute to knowledge that will help us all.”

— Joanne Waldstreicher, MD, Chief Medical Officer, Johnson & Johnson